Multiple actions of systemic artemin in experimental neuropathy

Luis R. Gardell; Ruizhong Wang; Chris Ehrenfels; Michael H. Ossipov; Anthony J. Rossomando; Stephan Miller; Carolyn Buckley; Amber K. Cai; Albert Tse; Susan F. Foley; Bang Jian Gong; Lee Walus; Paul Carmillo; Dane Worley; Carol Huang; Thomas Engber; Blake Pepinsky; Richard L. Cate; Todd W. Vanderah; Josephine Lai; Dinah W.Y. Sah; Frank Porreca

doi:10.1038/nm944

Multiple actions of systemic artemin in experimental neuropathy

Luis R. Gardell, Ruizhong Wang, Chris Ehrenfels, Michael H. Ossipov, Anthony J. Rossomando, Stephan Miller, Carolyn Buckley, Amber K. Cai, Albert Tse, Susan F. Foley, Bang Jian Gong, Lee Walus, Paul Carmillo, Dane Worley, Carol Huang, Thomas Engber, Blake Pepinsky, Richard L. Cate, Todd W. Vanderah, Josephine LaiDinah W.Y. Sah, Frank Porreca

Research output: Contribution to journal › Article › peer-review

147 Scopus citations

Abstract

The clinical management of neuropathic pain is particularly challenging. Current therapies for neuropathic pain modulate nerve impulse propagation or synaptic transmission; these therapies are of limited benefit and have undesirable side effects. Injuries to peripheral nerves result in a host of pathophysiological changes associated with the sustained expression of abnormal pain. Here we show that systemic, intermittent administration of artemin produces dose- and time-related reversal of nerve injury-induced pain behavior, together with partial to complete normalization of multiple morphological and neurochemical features of the injury state. These effects of artemin were sustained for at least 28 days. Higher doses of artemin than those completely reversing experimental neuropathic pain did not elicit sensory or motor abnormalities. Our results indicate that the behavioral symptoms of neuropathic pain states can be treated successfully, and that partial to complete reversal of associated morphological and neurochemical changes is achievable with artemin.

Original language	English (US)
Pages (from-to)	1383-1389
Number of pages	7
Journal	Nature Medicine
Volume	9
Issue number	11
DOIs	https://doi.org/10.1038/nm944
State	Published - Nov 2003

ASJC Scopus subject areas

General Biochemistry, Genetics and Molecular Biology

Access to Document

10.1038/nm944

Cite this

Gardell, L. R., Wang, R., Ehrenfels, C., Ossipov, M. H., Rossomando, A. J., Miller, S., Buckley, C., Cai, A. K., Tse, A., Foley, S. F., Gong, B. J., Walus, L., Carmillo, P., Worley, D., Huang, C., Engber, T., Pepinsky, B., Cate, R. L., Vanderah, T. W., ... Porreca, F. (2003). Multiple actions of systemic artemin in experimental neuropathy. Nature Medicine, 9(11), 1383-1389. https://doi.org/10.1038/nm944

Gardell, LR, Wang, R, Ehrenfels, C, Ossipov, MH, Rossomando, AJ, Miller, S, Buckley, C, Cai, AK, Tse, A, Foley, SF, Gong, BJ, Walus, L, Carmillo, P, Worley, D, Huang, C, Engber, T, Pepinsky, B, Cate, RL, Vanderah, TW, Lai, J, Sah, DWY & Porreca, F 2003, 'Multiple actions of systemic artemin in experimental neuropathy', Nature Medicine, vol. 9, no. 11, pp. 1383-1389. https://doi.org/10.1038/nm944

@article{96d3c70b735b44cd873df497b64561e1,

title = "Multiple actions of systemic artemin in experimental neuropathy",

abstract = "The clinical management of neuropathic pain is particularly challenging. Current therapies for neuropathic pain modulate nerve impulse propagation or synaptic transmission; these therapies are of limited benefit and have undesirable side effects. Injuries to peripheral nerves result in a host of pathophysiological changes associated with the sustained expression of abnormal pain. Here we show that systemic, intermittent administration of artemin produces dose- and time-related reversal of nerve injury-induced pain behavior, together with partial to complete normalization of multiple morphological and neurochemical features of the injury state. These effects of artemin were sustained for at least 28 days. Higher doses of artemin than those completely reversing experimental neuropathic pain did not elicit sensory or motor abnormalities. Our results indicate that the behavioral symptoms of neuropathic pain states can be treated successfully, and that partial to complete reversal of associated morphological and neurochemical changes is achievable with artemin.",

author = "Gardell, {Luis R.} and Ruizhong Wang and Chris Ehrenfels and Ossipov, {Michael H.} and Rossomando, {Anthony J.} and Stephan Miller and Carolyn Buckley and Cai, {Amber K.} and Albert Tse and Foley, {Susan F.} and Gong, {Bang Jian} and Lee Walus and Paul Carmillo and Dane Worley and Carol Huang and Thomas Engber and Blake Pepinsky and Cate, {Richard L.} and Vanderah, {Todd W.} and Josephine Lai and Sah, {Dinah W.Y.} and Frank Porreca",

year = "2003",

month = nov,

doi = "10.1038/nm944",

language = "English (US)",

volume = "9",

pages = "1383--1389",

journal = "Nature Medicine",

issn = "1078-8956",

publisher = "Nature Research",

number = "11",

}

TY - JOUR

T1 - Multiple actions of systemic artemin in experimental neuropathy

AU - Gardell, Luis R.

AU - Wang, Ruizhong

AU - Ehrenfels, Chris

AU - Ossipov, Michael H.

AU - Rossomando, Anthony J.

AU - Miller, Stephan

AU - Buckley, Carolyn

AU - Cai, Amber K.

AU - Tse, Albert

AU - Foley, Susan F.

AU - Gong, Bang Jian

AU - Walus, Lee

AU - Carmillo, Paul

AU - Worley, Dane

AU - Huang, Carol

AU - Engber, Thomas

AU - Pepinsky, Blake

AU - Cate, Richard L.

AU - Vanderah, Todd W.

AU - Lai, Josephine

AU - Sah, Dinah W.Y.

AU - Porreca, Frank

PY - 2003/11

Y1 - 2003/11

N2 - The clinical management of neuropathic pain is particularly challenging. Current therapies for neuropathic pain modulate nerve impulse propagation or synaptic transmission; these therapies are of limited benefit and have undesirable side effects. Injuries to peripheral nerves result in a host of pathophysiological changes associated with the sustained expression of abnormal pain. Here we show that systemic, intermittent administration of artemin produces dose- and time-related reversal of nerve injury-induced pain behavior, together with partial to complete normalization of multiple morphological and neurochemical features of the injury state. These effects of artemin were sustained for at least 28 days. Higher doses of artemin than those completely reversing experimental neuropathic pain did not elicit sensory or motor abnormalities. Our results indicate that the behavioral symptoms of neuropathic pain states can be treated successfully, and that partial to complete reversal of associated morphological and neurochemical changes is achievable with artemin.

AB - The clinical management of neuropathic pain is particularly challenging. Current therapies for neuropathic pain modulate nerve impulse propagation or synaptic transmission; these therapies are of limited benefit and have undesirable side effects. Injuries to peripheral nerves result in a host of pathophysiological changes associated with the sustained expression of abnormal pain. Here we show that systemic, intermittent administration of artemin produces dose- and time-related reversal of nerve injury-induced pain behavior, together with partial to complete normalization of multiple morphological and neurochemical features of the injury state. These effects of artemin were sustained for at least 28 days. Higher doses of artemin than those completely reversing experimental neuropathic pain did not elicit sensory or motor abnormalities. Our results indicate that the behavioral symptoms of neuropathic pain states can be treated successfully, and that partial to complete reversal of associated morphological and neurochemical changes is achievable with artemin.

UR - http://www.scopus.com/inward/record.url?scp=0344676390&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0344676390&partnerID=8YFLogxK

U2 - 10.1038/nm944

DO - 10.1038/nm944

M3 - Article

C2 - 14528299

AN - SCOPUS:0344676390

SN - 1078-8956

VL - 9

SP - 1383

EP - 1389

JO - Nature Medicine

JF - Nature Medicine

IS - 11

ER -

Multiple actions of systemic artemin in experimental neuropathy

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this